The genetic test reveals predispositions in peptide-pathway genes, not a guarantee of injection-site reactions or absorption outcomes
Disruption of this balance contributes to the pathophysiology of obesity, T2D, and maladaptive feeding behaviours, positioning the ghrelin-LEAP2 system as a biologically compelling yet complex therapeutic target [113, 161]
These behaviors can increase gastric pressure, trigger reflux, or irritate the diaphragm and prolong hiccups
Car model/vehicle model: Impreza/GC8
PLoS One 11:e0151511 Lavalle-Gonzalez FJ, Januszewicz A, Davidson J et al (2013) Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised trial